Pay in 4 interest-free payments of $6.06 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Teva Announces FDA Approval and Launch of Generic Saxenda (liraglutide injection) First Generic GLP-1 Indicated for Weight Loss Generic Saxenda is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S
Each product contains one core ingredient: omega-3 fatty acids, Aplha-GPC, and L-tyrosine
This quality-focused approach supports laboratories seeking a high-purity Melanotan II research peptide for scientific investigation involving melanocortin peptide research, receptor biology, molecular signaling, peptide chemistry, and experimental laboratory models
Imunotherapy in combination with chemotherapy is emerging as a new standard of care in this setting, and the approval of Imfinzi offers an important new option for patients with mismatch repair deficient disease, Dave Fredrickson, executive vice president of the oncology business unit at AstraZeneca, said in a press release
The GLP-1 program is the latest innovation from Denmark designed to help control weight and maintain it within a healthy range
US$ 27.29
US$ 27.82
US$ 24.47
